PBMC-humanized mouse model for the assessment of cytokine release syndrome caused by checkpoint and bispecific immunotherapy

被引：0
|
作者：
Cai, Danying [1 ]
Jiao, Jing [1 ]
Ye, Chunting [1 ]
Yang, Hongyuan [1 ]
Cheng, Mingshan [1 ]
Brehm, Michael A. [2 ]
Greiner, Dale L. [2 ]
Shultz, Leonard D. [3 ]
Keck, James G. [1 ]
机构：
[1] Jackson Lab, Sacramento, CA USA
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
[3] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5632
引用
收藏
页数：2
相关论文
共 38 条
  • [1] An in vivo PBMC humanized mouse model for determining checkpoint and bispecific antibody treatment related cytokine release syndrome
    Ye, Chunting
    Cheng, Mingshan
    Brehm, Michael
    Greiner, Dale
    Shultz, Leonard
    Keck, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Establishment and application of a panel of PBMC-humanized mouse tumor models in cancer immunotherapy
    Bourre, L.
    Zhang, L.
    Qi, S.
    Wu, H.
    Zhao, L.
    An, X.
    Tan, W.
    Fu, X.
    Qiao, M.
    Shi, Q.
    Yang, W.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] An in vivo humanized mouse model for determining donor-dependent cytokine release syndrome in response to checkpoint and bispecific antibody therapy
    Draheim, Kyle M.
    Yang, Jiwon
    Jiao, Jing
    Cheng, Mingshan
    Keck, James G.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [4] Increased sensitivity for detecting cytokine release syndrome with cancer immunotherapy using a PBMC humanized NSG-SGM3 mouse model
    Ye, Chunting
    Brehm, Michael
    Cheng, Mingshan
    Shultz, Leonard
    Greiner, Dale
    Keck, James
    CANCER RESEARCH, 2019, 79 (13)
  • [5] An in vivo method for determining cancer immunotherapy induced cytokine release syndrome utilizing PBMC humanized mice
    Ye, Chunting
    Cheng, Mingshan
    Brehm, Michael
    Greiner, Dale
    Shultz, Leonard
    Keck, James G.
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Establishment and application of a panel of PBMC-humanized mouse tumor models in immune-oncology and targeted cancer immunotherapy
    Zhang, Lan
    Wu, Haochen
    Chen, Fei
    Zhao, Lianqi
    An, Xiaoyu
    Tan, Weibin
    Fu, Xiaoyan
    Qiao, Meng
    Shi, Qian
    Yang, Wenqing
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Establishment and application of a panel of PBMC-humanized mouse tumor models in immune-oncology and targeted cancer immunotherapy
    Zhang, L.
    Qi, S.
    Jin, Y.
    Wu, H.
    Chen, F.
    Zhao, L.
    An, X.
    Tan, W.
    Fu, X.
    Qiao, M.
    Shi, Q.
    Yang, W.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E83 - E84
  • [8] TGN1412 induces dose and time dependent human cytokines in a humanized PBMC mouse model for cytokine release syndrome
    Yang, Hongyuan
    Jiao, Jing
    Cai, Danying
    Cheng, Mingshan
    Brehm, Michael
    Grainer, Dale
    Shultz, Leonard
    Keck, James
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunotherapy using a PBMC-humanized mouse model
    Lee, Won
    Rose, Destanie
    Burleigh, Katelyn
    Armstrong, Blair
    Gustafson, Heather
    Gardner, Rebecca
    Keck, James G.
    Yang, Jiwon
    CANCER RESEARCH, 2023, 83 (07)
  • [10] PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Universal CD19 Chimeric Antigen Receptor T Cell Immunotherapy
    Lee, Won
    Rose, Destanie
    Gustafson, Heather
    Jackson, Meredith
    Gwiazda, Kamila
    Gustafson, Joshua
    Ott, Mariliis
    Gardner, Rebecca
    Keck, James G.
    Yang, Jiwon
    BLOOD, 2023, 142
1234